Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-13

Clinical Trial Update: Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on flutamide for prevention of prostate cancer in patients with neoplasia of the prostate; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • flutamide (flutamide)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED